clinical decision support
Over 70% Accuracy: ChatGPT Shows Promise in Clinical Decision Support
A study assessing ChatGPT's utility in clinical decision-making found it has a 71.7% overall accuracy in clinical vignettes, excelling in final diagnoses with 76.9% accuracy. This highlights its potential as an AI tool in healthcare workflows.
Blockchain as a Solution for Data Management in Clinical Trials
Applying blockchain technology to clinical trials can help resolve one of the industry's biggest weaknesses: Poor data management. Learn how blockchain's immutability trait can become a trial investigator's best asset.
SEC Reschedules Decision-Making on Bitcoin ETF Proposals
The Securities and Exchange Commission (SEC) in the United States once again delayed on deciding on the three Bitcoin exchange-traded fund (ETF) proposals according to the release of documents from the regulatory agency on Monday.
Elon Musk Reverses Decision to Sell NFT, but not before Setting an Asking Price of 420M Dogecoins
Elon Musk expressed his wish to sell his NFT for 420 million Dogecoins. This would translate to a total profit of around $24.26 million. However, the Tesla CEO seems to have come back on his decision. What has happened to DOGE's price in the meantime?
HashCash Consultants to Streamline Drug Research and Clinical Trials with Blockchain
HashCash Consultants, a US-based blockchain development company, has set its eyes on revamping the complex process of clinical trials and drug research by availing blockchain solutions. It intends to realize this by forming a pharma consortium with pharmaceutical firms and other medical players.
Deutsche Bank Executive Says CBDC is More of a Political Decision
Deutsche Bank Executive Burkhard Balz has noted that the decision to launch a CBDC by any country may be more of a political decision than a technical one.
Binance Delists FTX Tokens Due to Crypto Users' Lack of Understanding
Binance, the world’s largest crypto exchange by trading volume, has made a tough decision to delist all FTX leveraged tokens, citing that customers did not understand how the tokens work. The exchange intends to shut off withdrawals and deposits for the assets on March 31 at 8 a.m. UTC and to stop trading at 10 a.m. on the same day. The decision has sparked mixed reactions. Some users support the decision while others want the leveraged tokens to remain on the crypto exchange platform.
Coinbase Considers Support for 18 New Cryptos Including VeChain, Prompting Higher Prices
Coinbase is considering adding a new range of digital assets, including VeChain, Aragon, Bancor, Siacoin, Origin Protocol, and Ren to its potential listings.
Grayscale Investments Removes XRP from Its Fund and Rebalances Bitcoin, Ethereum, Litecoin, and BCH Assets
Grayscale Investments has joined other exchanges and funds in removing its support of Ripple’s XRP token.
US SEC Reopens Rejected Bitwise BTC ETF For Review
The United States Securities and Exchange Commission (SEC) has announced that it will revisit and review its previous decision to reject Bitwise Asset Management and NYSE Arca’s filing for a Bitcoin (BTC) exchange-traded fund (ETF).
SEC Delays Decision on Overstock-Backed Security Token Exchange
The SEC has extended the timeline for its to disapprove or approve operations by the BSTX, a security token exchanged affiliated with Overstock’s blockchain arm tZERO.
Bitcoin Price Needs to Stay Above This Support Level in Order to Hit a New All-Time High as Whales Decline
Cryptocurrency analytics firm Santiment noted that the number of Bitcoin wallets with different amounts of holdings have seen a change this month.
AAVE Price Analysis: AAVE Fails To Sustain Support At $200
Aave price has dropped below the $200 support level it has held for days. Technical indicators show that more imminent dips are likely.